Poliomyelitis prevention: Revised recommendations for use of inactivated and live oral poliovirus vaccines

N. A. Halsey, J. S. Abramson, P. J. Chesney, M. C. Fisher, M. A. Gerber, S. M. Marcy, D. L. Murray, G. D. Overturf, C. G. Prober, T. Saari, L. B. Weiner, R. J. Whitley, G. Peter, L. K. Pickering, C. J. Baker, A. T. Hirsch, R. F. Jacobs, N. E. MacDonald, B. Schwartz, W. A. OrensteinM. C. Hardegree, N. R. Rabinovich, R. F. Breiman

Research output: Contribution to journalShort survey

34 Citations (Scopus)

Abstract

Since 1997 when the American Academy of Pediatrics (AAP) issued revised guidelines for the prevention of poliomyelitis, substantial progress in global eradication of poliomyelitis has occurred and the use of inactivated poliovirus vaccine (IPV) has increased considerably in the United States with a corresponding decrease in the use of oral poliovirus vaccine (OPV). Surveys indicate that the majority of physicians now routinely immunize children with the sequential IPV-OPV or IPV-only regimens. Nevertheless, vaccine-associated paralytic poliomyelitis (VAPP) continues to occur, albeit infrequently, in children who have received the OPV-only regimen and their contacts. To reduce further the risk of VAPP, the AAP now recommends that children in the United States receive IPV for the first 2 doses of the polio vaccine series in most circumstances. Exceptions include a parent's refusal to permit the number of injections necessary to administer the other routinely recommended vaccines at the 2- and 4-month visits. Either IPV or OPV can be administered for the third and fourth doses. Assuming continuing progress toward global eradication, a recommendation of IPV-only immunization for children in the United States is anticipated by 2001.

Original languageEnglish (US)
Pages (from-to)171-172
Number of pages2
JournalPediatrics
Volume103
Issue number1
DOIs
StatePublished - Jan 1 1999

Fingerprint

Inactivated Poliovirus Vaccine
Oral Poliovirus Vaccine
Poliomyelitis
Vaccines
Pediatrics
Immunization
Parents
Guidelines
Physicians
Injections

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

Halsey, N. A., Abramson, J. S., Chesney, P. J., Fisher, M. C., Gerber, M. A., Marcy, S. M., ... Breiman, R. F. (1999). Poliomyelitis prevention: Revised recommendations for use of inactivated and live oral poliovirus vaccines. Pediatrics, 103(1), 171-172. https://doi.org/10.1542/peds.103.1.171

Poliomyelitis prevention : Revised recommendations for use of inactivated and live oral poliovirus vaccines. / Halsey, N. A.; Abramson, J. S.; Chesney, P. J.; Fisher, M. C.; Gerber, M. A.; Marcy, S. M.; Murray, D. L.; Overturf, G. D.; Prober, C. G.; Saari, T.; Weiner, L. B.; Whitley, R. J.; Peter, G.; Pickering, L. K.; Baker, C. J.; Hirsch, A. T.; Jacobs, R. F.; MacDonald, N. E.; Schwartz, B.; Orenstein, W. A.; Hardegree, M. C.; Rabinovich, N. R.; Breiman, R. F.

In: Pediatrics, Vol. 103, No. 1, 01.01.1999, p. 171-172.

Research output: Contribution to journalShort survey

Halsey, NA, Abramson, JS, Chesney, PJ, Fisher, MC, Gerber, MA, Marcy, SM, Murray, DL, Overturf, GD, Prober, CG, Saari, T, Weiner, LB, Whitley, RJ, Peter, G, Pickering, LK, Baker, CJ, Hirsch, AT, Jacobs, RF, MacDonald, NE, Schwartz, B, Orenstein, WA, Hardegree, MC, Rabinovich, NR & Breiman, RF 1999, 'Poliomyelitis prevention: Revised recommendations for use of inactivated and live oral poliovirus vaccines', Pediatrics, vol. 103, no. 1, pp. 171-172. https://doi.org/10.1542/peds.103.1.171
Halsey NA, Abramson JS, Chesney PJ, Fisher MC, Gerber MA, Marcy SM et al. Poliomyelitis prevention: Revised recommendations for use of inactivated and live oral poliovirus vaccines. Pediatrics. 1999 Jan 1;103(1):171-172. https://doi.org/10.1542/peds.103.1.171
Halsey, N. A. ; Abramson, J. S. ; Chesney, P. J. ; Fisher, M. C. ; Gerber, M. A. ; Marcy, S. M. ; Murray, D. L. ; Overturf, G. D. ; Prober, C. G. ; Saari, T. ; Weiner, L. B. ; Whitley, R. J. ; Peter, G. ; Pickering, L. K. ; Baker, C. J. ; Hirsch, A. T. ; Jacobs, R. F. ; MacDonald, N. E. ; Schwartz, B. ; Orenstein, W. A. ; Hardegree, M. C. ; Rabinovich, N. R. ; Breiman, R. F. / Poliomyelitis prevention : Revised recommendations for use of inactivated and live oral poliovirus vaccines. In: Pediatrics. 1999 ; Vol. 103, No. 1. pp. 171-172.
@article{88e2aa3c16f049439332c5193a40e7ed,
title = "Poliomyelitis prevention: Revised recommendations for use of inactivated and live oral poliovirus vaccines",
abstract = "Since 1997 when the American Academy of Pediatrics (AAP) issued revised guidelines for the prevention of poliomyelitis, substantial progress in global eradication of poliomyelitis has occurred and the use of inactivated poliovirus vaccine (IPV) has increased considerably in the United States with a corresponding decrease in the use of oral poliovirus vaccine (OPV). Surveys indicate that the majority of physicians now routinely immunize children with the sequential IPV-OPV or IPV-only regimens. Nevertheless, vaccine-associated paralytic poliomyelitis (VAPP) continues to occur, albeit infrequently, in children who have received the OPV-only regimen and their contacts. To reduce further the risk of VAPP, the AAP now recommends that children in the United States receive IPV for the first 2 doses of the polio vaccine series in most circumstances. Exceptions include a parent's refusal to permit the number of injections necessary to administer the other routinely recommended vaccines at the 2- and 4-month visits. Either IPV or OPV can be administered for the third and fourth doses. Assuming continuing progress toward global eradication, a recommendation of IPV-only immunization for children in the United States is anticipated by 2001.",
author = "Halsey, {N. A.} and Abramson, {J. S.} and Chesney, {P. J.} and Fisher, {M. C.} and Gerber, {M. A.} and Marcy, {S. M.} and Murray, {D. L.} and Overturf, {G. D.} and Prober, {C. G.} and T. Saari and Weiner, {L. B.} and Whitley, {R. J.} and G. Peter and Pickering, {L. K.} and Baker, {C. J.} and Hirsch, {A. T.} and Jacobs, {R. F.} and MacDonald, {N. E.} and B. Schwartz and Orenstein, {W. A.} and Hardegree, {M. C.} and Rabinovich, {N. R.} and Breiman, {R. F.}",
year = "1999",
month = "1",
day = "1",
doi = "10.1542/peds.103.1.171",
language = "English (US)",
volume = "103",
pages = "171--172",
journal = "Pediatrics",
issn = "0031-4005",
publisher = "American Academy of Pediatrics",
number = "1",

}

TY - JOUR

T1 - Poliomyelitis prevention

T2 - Revised recommendations for use of inactivated and live oral poliovirus vaccines

AU - Halsey, N. A.

AU - Abramson, J. S.

AU - Chesney, P. J.

AU - Fisher, M. C.

AU - Gerber, M. A.

AU - Marcy, S. M.

AU - Murray, D. L.

AU - Overturf, G. D.

AU - Prober, C. G.

AU - Saari, T.

AU - Weiner, L. B.

AU - Whitley, R. J.

AU - Peter, G.

AU - Pickering, L. K.

AU - Baker, C. J.

AU - Hirsch, A. T.

AU - Jacobs, R. F.

AU - MacDonald, N. E.

AU - Schwartz, B.

AU - Orenstein, W. A.

AU - Hardegree, M. C.

AU - Rabinovich, N. R.

AU - Breiman, R. F.

PY - 1999/1/1

Y1 - 1999/1/1

N2 - Since 1997 when the American Academy of Pediatrics (AAP) issued revised guidelines for the prevention of poliomyelitis, substantial progress in global eradication of poliomyelitis has occurred and the use of inactivated poliovirus vaccine (IPV) has increased considerably in the United States with a corresponding decrease in the use of oral poliovirus vaccine (OPV). Surveys indicate that the majority of physicians now routinely immunize children with the sequential IPV-OPV or IPV-only regimens. Nevertheless, vaccine-associated paralytic poliomyelitis (VAPP) continues to occur, albeit infrequently, in children who have received the OPV-only regimen and their contacts. To reduce further the risk of VAPP, the AAP now recommends that children in the United States receive IPV for the first 2 doses of the polio vaccine series in most circumstances. Exceptions include a parent's refusal to permit the number of injections necessary to administer the other routinely recommended vaccines at the 2- and 4-month visits. Either IPV or OPV can be administered for the third and fourth doses. Assuming continuing progress toward global eradication, a recommendation of IPV-only immunization for children in the United States is anticipated by 2001.

AB - Since 1997 when the American Academy of Pediatrics (AAP) issued revised guidelines for the prevention of poliomyelitis, substantial progress in global eradication of poliomyelitis has occurred and the use of inactivated poliovirus vaccine (IPV) has increased considerably in the United States with a corresponding decrease in the use of oral poliovirus vaccine (OPV). Surveys indicate that the majority of physicians now routinely immunize children with the sequential IPV-OPV or IPV-only regimens. Nevertheless, vaccine-associated paralytic poliomyelitis (VAPP) continues to occur, albeit infrequently, in children who have received the OPV-only regimen and their contacts. To reduce further the risk of VAPP, the AAP now recommends that children in the United States receive IPV for the first 2 doses of the polio vaccine series in most circumstances. Exceptions include a parent's refusal to permit the number of injections necessary to administer the other routinely recommended vaccines at the 2- and 4-month visits. Either IPV or OPV can be administered for the third and fourth doses. Assuming continuing progress toward global eradication, a recommendation of IPV-only immunization for children in the United States is anticipated by 2001.

UR - http://www.scopus.com/inward/record.url?scp=0033044160&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033044160&partnerID=8YFLogxK

U2 - 10.1542/peds.103.1.171

DO - 10.1542/peds.103.1.171

M3 - Short survey

C2 - 9917460

AN - SCOPUS:0033044160

VL - 103

SP - 171

EP - 172

JO - Pediatrics

JF - Pediatrics

SN - 0031-4005

IS - 1

ER -